TET1 and colonic neoplasm: Therefore, the upregulation of TET1 in HCT116 colon cancer cells not only suppresses their proliferation but also may improve drug resistance to 5-aza-dC in our system, and the role of the DMNT inhibitor may involve maintaining the expression level of TET1.